JENNIFER HARDY: Open Payments
NPI 1730370669 · DAYVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 9 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $0 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $119 |
| Phathom Pharmaceuticals, Inc. | 1 | $91 |
| ABBVIE INC. | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $33 |
| Philips North America LLC | 1 | $30 |
| Exact Sciences Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: Ozempic, VOQUEZNA, QULIPTA, Azurion 7 M20, Cologuard Collection Kit, GVOKE HYPOPEN.
Industry payments across CT — which companies pay providers there.
